This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Emory University, Merck Sharp & Dohme LLC. Active years: 2026.
Company Filing History:
1 out of 1,023 
1 out of 64 Years Active: 2026
Title: Andrew Patrick Jude Brunskill - Innovator in Cyclic Dinucleotide Compounds
Introduction
Andrew Patrick Jude Brunskill is an inventor based in Watchung, NJ (US). He is known for his innovative work in the field of cyclic dinucleotide compounds. Although he currently holds no granted patents, his contributions to the field are noteworthy.
Latest Patent Applications
Brunskill's latest patent application is titled "NOVEL FORMS OF CYCLIC DINUCLEOTIDE COMPOUNDS." This application details novel forms of 2-amino-9-[(2R,5R,7R,8S,10R,12aR, 14R,15S,15aR,16R)-14-(6-amino-9H-purin-9-yl)-15,16-difluoro-2,10-dihydroxy-2,10-disulfidooctahydro-12H-5,8-methanofuro[3,2-1][1,3,6,9,11,2,10]pentaoxadiphospha-cyclotetradecin-7-yl]-1,9-dihydro-6H-purin-6-one. The application also discusses adducts of this compound with L-histidine, which may serve as inductors of type I interferon production, specifically as STING active agents.
Conclusion
Andrew Patrick Jude Brunskill is an innovative inventor whose work in cyclic dinucleotide compounds holds potential for significant advancements in medical applications. His latest patent application reflects his commitment to exploring new frontiers in this field.